Error loading player: No playable sources found

Monitoring population-level disease prevalence by measuring SARS-CoV2 in wastewater across a large geographical range

Date
April 21, 2022
Free
Standard Price
This product is also available as part of the following products:

There is a need for wastewater based epidemiological (WBE) methods that integrate multiple,
variously sized surveillance sites across geographic areas. We developed a novel indexing method,
Melvin’s Index, that provides a normalized and standardized metric of wastewater pathogen load
for qPCR assays that is resilient to surveillance site variation. To demonstrate the utility of Melvin’s
Index, we used qRT-PCR to measure SARS-CoV-2 genomic RNA levels in influent wastewater from 19
municipal wastewater treatment facilities (WWTF’s) of varying sizes and served populations across the
state of Minnesota during the Summer of 2020. SARS-CoV-2 RNA was detected at each WWTF during
the 20-week sampling period at a mean concentration of 8.5 × 104
genome copies/L (range 3.2 × 102–
1.2 × 109
genome copies/L). Lag analysis of trends in Melvin’s Index values and clinical COVID-19
cases showed that increases in indexed wastewater SARS-CoV-2 levels precede new clinical cases by
15–17 days at the statewide level and by up to 25 days at the regional/county level. Melvin’s Index is
a reliable WBE method and can be applied to both WWTFs that serve a wide range of population sizes
and to large regions that are served by multiple WWTFs.

Speaker

Speaker Image for Glenn Simmons Jr
Cornell UniversityCollege of Veterinary Medicine

Related Products

Thumbnail for Anti-CD19, B cell Inhibiting, Non-depleting Antibody: Novel Approach for the Treatment of Autoimmunity
Anti-CD19, B cell Inhibiting, Non-depleting Antibody: Novel Approach for the Treatment of Autoimmunity
B cells contribute to multiple aspects of autoimmune disorders through autoantibody production, antigen presentation, cytokine secretion, and formation of tertiary lymphoid structures. B cell targeting therapies have been developed and approved for treatment of autoimmune diseases…
Thumbnail for Understanding and De-risking Drug-induced Injection Site Reactions (ISRs) with an Immunocompetent Human Skin Model
Understanding and De-risking Drug-induced Injection Site Reactions (ISRs) with an Immunocompetent Human Skin Model
Upon subcutaneous (SQ) injection of therapeutic drugs, a local inflammatory reaction, commonly referred to as an injection site reaction (ISR), may develop at the injection site. ISRs are characterized by one or more of the following, erythema, edema, pruritus, pain, and induration…
Thumbnail for Neural mechanisms underlying GIP’s anti-nausea effect
Neural mechanisms underlying GIP’s anti-nausea effect
Neural mechanism underlying the anti-nausea effect of GIP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.